Literature DB >> 28256032

Localization of the 5-hydroxytryptamine 4 receptor in equine enteric neurons and extrinsic sensory fibers.

F Giancola1,2, A M Rambaldi1, F Bianco1,2, S Iusco1, N Romagnoli1, C Tagliavia1, C Bombardi1, P Clavenzani1, R De Giorgio2, R Chiocchetti1.   

Abstract

BACKGROUND: Serotonin plays a pivotal role in regulating gut motility, visceral sensitivity, and fluid secretion via specific receptors. Among these receptors, 5-HT4 exerts a prominent control on gut motor function. Although the prokinetic effect exerted by 5-HT4 agonists is well known, the cellular sites of 5-HT4 expression remain poorly understood in large mammals, e.g., horses. In this study, we evaluated the distribution of 5-HT4 in the horse intestine and in foals with enteric aganglionosis, reminiscent of human Hirschsprung's disease.
METHODS: The intestine and spinal ganglia were obtained from three healthy horses and two foals with hereditary ileocolonic aganglionosis. Tissues were processed for immunohistochemistry using a specific antibody to 5-HT4 and a variety of neuronal markers. Myenteric and submucosal plexus 5-HT4 -immunoreactive (IR) neurons were quantified as relative percentage (mean±SD) to the total number of neurons counted. Furthermore, the density of 5-HT4 -IR nerve fibers was evaluated in the mucosa and tunica muscularis. KEY
RESULTS: The 5-HT4 immunoreactivity was localized to large percentages of myenteric neurons ranging from 28±9% (descending colon) to 63±19% (ileum), and submucosal neurons ranging from 54±6% (ileum) to 68±14% (duodenum). The 5-HT4 -immunoreactivity was co-expressed by some substance P-IR (SP-IR) spinal ganglion neurons and extrinsic sensory fibers of aganglionic foals. CONCLUSIONS & INFERENCES: The presence of 5-HT4 in many enteric and extrinsic sensory neurons and nerve fibers provides solid morphological evidence of the cellular sites of 5-HT4 expression in horses. The evidence of SP-IR sensory neurons positive for 5-HT4 suggests its role in visceral sensitivity.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  5-hydroxytryptamine receptor type 4; enteric nervous system; lethal white foal syndrome; prokinetic; serotonin

Mesh:

Substances:

Year:  2017        PMID: 28256032     DOI: 10.1111/nmo.13045

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  5 in total

1.  Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract.

Authors:  Giorgia Galiazzo; Fiorella Giancola; Agnese Stanzani; Federico Fracassi; Chiara Bernardini; Monica Forni; Marco Pietra; Roberto Chiocchetti
Journal:  Histochem Cell Biol       Date:  2018-06-07       Impact factor: 4.304

Review 2.  Gastrointestinal mucosal biopsies in Parkinson's disease: beyond alpha-synuclein detection.

Authors:  Pascal Derkinderen; François Cossais; Adrien de Guilhem de Lataillade; Laurène Leclair-Visonneau; Michel Neunlist; Sébastien Paillusson; Roberto De Giorgio
Journal:  J Neural Transm (Vienna)       Date:  2021-11-24       Impact factor: 3.850

3.  Localization of the Serotonin Transporter in the Dog Intestine and Comparison to the Rat and Human Intestines.

Authors:  Roberto Chiocchetti; Giorgia Galiazzo; Fiorella Giancola; Claudio Tagliavia; Chiara Bernardini; Monica Forni; Marco Pietra
Journal:  Front Vet Sci       Date:  2022-01-05

4.  Ex vivo ultrasonographic and histological morphometry of small intestinal wall layers in horses.

Authors:  Alessia Diana; Francesca Freccero; Fiorella Giancola; Nikolina Linta; Marco Pietra; Valeria Luca; Giulia Salamanca; Mario Cipone; Roberto Chiocchetti
Journal:  Vet Radiol Ultrasound       Date:  2022-02-16       Impact factor: 1.318

5.  Cellular distribution of cannabinoid-related receptors TRPV1, PPAR-gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia.

Authors:  Giorgia Galiazzo; Margherita De Silva; Fiorella Giancola; Riccardo Rinnovati; Angelo Peli; Roberto Chiocchetti
Journal:  Equine Vet J       Date:  2021-08-21       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.